Floatz logo

Acetylsalicylic Acid

Myocardial Infarction

Shanghai CureGene Pharmaceutical Co., Ltd.Phase 4 / ApprovedActive
A
83/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
75/ 100
Competitive Position
95/ 100

Competitive context

9 Active assets in the Myocardial Infarction cohort.

Asset / SponsorPhaseRating
Plavix
Shanghai CureGene Pharmaceutical Co., Ltd.
Phase 4A
Ticagrelor
Assistance Publique - Hôpitaux de Paris
Phase 4BBB
Vitamin B6
Hamilton Health Sciences Corporation
Phase 4BBB
Folic Acid
Hamilton Health Sciences Corporation
Phase 4BBB
ATENOLOL
The George Institute
Phase 4BB

View all 37 →

Same molecule, other indications

Acetylsalicylic Acid is also rated in:

coronary artery disorderDormant
BBB
Indicative ·
79 / 100
View asset →
cardiovascular disorderDormant
BBB
Indicative ·
78 / 100
View asset →
transient ischemic attackDormant
BBB
Indicative ·
77 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →